To Promote or Not to Promote? The Enforceability of FDA’s Off-Label Marketing Restrictions Following Amarin
- February 01, 2016
- Matthew T. Newcomer , Post & Schell, P.C.
- Yune T. Do , Post & Schell, P.C.
You must be logged in to access this content.
You must be logged in to access this content.